Overview

Metronomic PLD in Patients With Primary Endocrine Resistant ABC

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Metronomic PLD in Patients with Primary Endocrine Resistant ABC
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Doxorubicin
Liposomal doxorubicin